Hyloris Lays Out Ambitious Plans For US

Value Added Medicines Specialist Reveals How It Will Use IPO Proceeds

Stijin van_Rompay
Stijn Van Rompay lays out Hyloris’ strategy • Source: Hyloris

More from Value Added Medicines

More from Products